Case Type: Mergers & Acquisitions

Eagle Bulk Shipping Inc. (NYSE: EGLE), relating to its proposed merger with Star Bulk Carriers Corp. Under the terms of the agreement, EGLE shareholders will receive 2.6211 shares of Star Bulk per share they own.

Icosavax, Inc. (Nasdaq: ICVX), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, ICVX shareholders are expected to receive $15.00 in cash and one non-tradeable CVR worth up to $5.00 per share they own.

Evofem Biosciences, Inc. (OTC: EVFM), relating to its proposed sale to Aditxt, Inc.

Codorus Valley Bancorp, Inc. (Nasdaq: CVLY), relating to its proposed sale to Orrstown Financial Services, Inc. Under the terms of the agreement, CVLY shareholders are expected to own approximately 44% of the outstanding shares of the combined company.

National Western Life Group, Inc. (Nasdaq: NWLI), relating to its proposed sale to Prosperity Life Group. Under the terms of the agreement, NWLI shareholders are expected to receive $500.00 in cash per share they own.

Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), relating to its proposed sale to AbbVie Inc. Under the terms of the agreement, CERE shareholders are expected to receive $45.00 in cash per share they own.

Hawaiian Holdings, Inc. (Nasdaq: HA), relating to its proposed sale to Alaska Air Group, Inc. Under the terms of the agreement, HA shareholders will receive $18.00 in cash per share they own.

Graphite Bio, Inc. (Nasdaq: GRPH), relating to its proposed merger with LENZ Therapeutics. Under the terms of the agreement, GRPH shareholders will own approximately 35% of the combined company.

WaveDancer, Inc. (Nasdaq: WAVD), relating to its proposed merger with Firefly Neuroscience, Inc. Under the terms of the agreement, WAVD shareholders will own approximately 8% of the combined company.

Rover Group, Inc. (Nasdaq: ROVR), relating to its sale to affiliates of Blackstone Inc. Under the terms of the agreement, ROVR shareholders will receive $11.00 in cash pers share they own.